Qiagen begins early access of NGS analysis tool; mHealth sector set to swell to $58.8B;

> Qiagen ($QGEN) has begun an early access program for its web-based NGS data interpretation tool. Release

> The mHealth market is expected to swell to $58.8 billion by 2020. Report

> Endpoint Clinical is planning to open a European headquarters early next year. News

> Actelion Pharmaceuticals ($ATLN) is using Wingspan's eTMF to organize its digital clinical trial files. Post

> Digital Science has invested in ÜberResearch and its cloud-based research grant tool. Piece

> OmniComm Systems has acquired clinical trial software business Promasys. Release

> Veeva Systems ($VEEV) has made its CRM and CLM systems available on Windows 8. Item

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.